Group 1 - The core viewpoint of the article is that Xiangyu Medical has successfully entered the list of projects for the 2025 Artificial Intelligence Medical Device Innovation Task with its "Closed-loop Transcranial Stimulation System for Treatment-Resistant Depression" project [2] Group 2 - The project is led by the company and aims to address treatment-resistant depression, indicating a focus on innovative solutions in the mental health sector [2] - The inclusion in the innovation task list highlights the company's commitment to advancing medical technology and its potential impact on the healthcare industry [2]

Group 1 - The company, Xiangyu Medical, confirmed its participation in the Ministry of Industry and Information Technology's AI medical device initiative, specifically for a project targeting treatment-resistant depression with a closed-loop transcranial stimulation system [2] - The project led by the company has successfully made it to the list of innovative tasks for AI medical devices set for 2025 [2]